But theyre also very expensive, and insurers are trying to control spiraling costs
For all the hype, the weekly shots have been awfully hard to get ahold of
Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus

Monitoring Potential Side Effects Despite its overall safety profile, semaglutide GLP-1 does have potential adverse effects, including digestive problems such as constipation, diarrhea, nausea, and abdominal discomfort
Always get medications from a licensed pharmacy with a valid prescription
PlexusDx personalizes your semaglutide dosing to account for post-surgical bile flow changes, starting conservatively and advancing only as your body tolerates